BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 31892254)

  • 1. Precision Medicine in Neurodegenerative Diseases: Some Promising Tips Coming from the microRNAs' World.
    Nuzziello N; Ciaccia L; Liguori M
    Cells; 2019 Dec; 9(1):. PubMed ID: 31892254
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative Disorders.
    Gupta S; Verma S; Mantri S; Berman NE; Sandhir R
    Drug Dev Res; 2015 Nov; 76(7):397-418. PubMed ID: 26359796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal microRNAs as diagnostic biomarkers and therapeutic applications in neurodegenerative diseases.
    Sataer X; Qifeng Z; Yingying Z; Chunhua H; Bingzhenga F; Zhiran X; Wanli L; Yuwei Y; Shuangfeng C; Lingling W; Hongri H; Jibing C; Xiaoping R; Hongjun G
    Neurol Res; 2023 Mar; 45(3):191-199. PubMed ID: 36184105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in neurodegenerative diseases and their therapeutic potential.
    Junn E; Mouradian MM
    Pharmacol Ther; 2012 Feb; 133(2):142-50. PubMed ID: 22008259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MicroRNA Centrism in the Orchestration of Neuroinflammation in Neurodegenerative Diseases.
    Nuzziello N; Liguori M
    Cells; 2019 Oct; 8(10):. PubMed ID: 31581723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs with a role in gene regulation and in human diseases.
    Ullah S; John P; Bhatti A
    Mol Biol Rep; 2014 Jan; 41(1):225-32. PubMed ID: 24197698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs -the next generation therapeutic targets in human diseases.
    Srinivasan S; Selvan ST; Archunan G; Gulyas B; Padmanabhan P
    Theranostics; 2013 Nov; 3(12):930-42. PubMed ID: 24396504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics.
    Roy B; Lee E; Li T; Rampersaud M
    Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNAs in drug response variability: potential utility as biomarkers for personalized medicine.
    Latini A; Borgiani P; Novelli G; Ciccacci C
    Pharmacogenomics; 2019 Sep; 20(14):1049-1059. PubMed ID: 31559917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodegenerative Disorders Treatment: The MicroRNA Role.
    Ridolfi B; Abdel-Haq H
    Curr Gene Ther; 2017; 17(5):327-363. PubMed ID: 29357791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNAs and Neurodegenerative Diseases.
    Qiu L; Tan EK; Zeng L
    Adv Exp Med Biol; 2015; 888():85-105. PubMed ID: 26663180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNAs Identify Shared Pathways in Alzheimer's and Parkinson's Diseases.
    Sadlon A; Takousis P; Alexopoulos P; Evangelou E; Prokopenko I; Perneczky R
    Trends Mol Med; 2019 Aug; 25(8):662-672. PubMed ID: 31221572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancing personalized medicine in neurodegenerative diseases: The role of epigenetics and pharmacoepigenomics in pharmacotherapy.
    Griñán-Ferré C; Bellver-Sanchis A; Guerrero A; Pallàs M
    Pharmacol Res; 2024 Jul; 205():107247. PubMed ID: 38834164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
    Duarte FV; Palmeira CM; Rolo AP
    Adv Exp Med Biol; 2015; 888():123-54. PubMed ID: 26663182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of microRNA-485 in neurodegenerative diseases.
    Ryu IS; Kim DH; Cho HJ; Ryu JH
    Rev Neurosci; 2023 Jan; 34(1):49-62. PubMed ID: 35793556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Map of the microRNA Regulatory Networks Identified by Experimentally Validated microRNA-Target Interactions in Five Domestic Animals: Cattle, Pig, Sheep, Dog, and Chicken.
    Pasquini G; Kunej T
    OMICS; 2019 Sep; 23(9):448-456. PubMed ID: 31381467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNAs as biomarkers of neurodegenerative disorders.
    Viswambharan V; Thanseem I; Vasu MM; Poovathinal SA; Anitha A
    Biomark Med; 2017 Feb; 11(2):151-167. PubMed ID: 28125293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs: novel therapeutic targets in neurodegenerative diseases.
    Roshan R; Ghosh T; Scaria V; Pillai B
    Drug Discov Today; 2009 Dec; 14(23-24):1123-9. PubMed ID: 19822222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs change the games in central nervous system pharmacology.
    Marangon D; Raffaele S; Fumagalli M; Lecca D
    Biochem Pharmacol; 2019 Oct; 168():162-172. PubMed ID: 31251938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine.
    Kovacs GG
    Int J Mol Sci; 2016 Feb; 17(2):. PubMed ID: 26848654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.